Virginia / 2026 Regular Session

2026 Regular Session · Imported snapshot

HB631: State pharmacy benefits manager; contractual provisions, report.

failed committee

<b>State pharmacy benefits manager; contractual provisions; report.</b> Requires the Department of Medical Assistance Services' contract with the state pharmacy benefits manager to (i) require that that ingredient-cost reimbursement is based on the national average drug acquisition cost, or if unavailable, the wholesale acquisition cost minus a discount set by the Department, plus a professional dispensing fee, determined by the Department; (ii) require real-time or near real-time transparency in drug costs, rebates collected and paid, dispensing fees paid, administrative fees, and all other charges, fees, costs, and holdbacks, claim denials appeals, and network participation; (iii) prohibit the state pharmacy benefits manager from steering Medicaid recipients to affiliated pharmacies through differential cost-sharing, restrictive network design, or the mandatory use of a mail order pharmacy provider; (iv) require the state pharmacy benefits manager to (a) meet network adequacy standards established by the Department; (b) allow any willing pharmacy to participate in the pharmacy network; (c) verify that all contracted pharmacies are actively accepting Medicaid recipients; (d) submit annual reports containing certain information; (e) disclose to the Department pricing and maximum acquisition cost methodologies; and (f) allow invoice-based or national average drug acquisition cost-based appeals and require an adjustment of rates network-wide when an appeal is upheld; and (v) include enforcement mechanisms and monetary penalties for noncompliance. Additionally, the bill requires Department to annually calculate the savings generated by the use of the state pharmacy benefits manager and to annually increase its dispensing fee by the amount of such savings. The bill requires the Department to annually (1) publish and make available on its website its annual and total savings achieved, the annual and total amount applied to dispensing fees increases, and the updated dispensing fees and (2) report to the General Assembly on the state pharmacy benefits manager's compliance, national average drug acquisition cost compliance, pharmacy reimbursement trends, network adequacy compliance, and dispensing fee sufficiency.

Official bill page · Source: Richmond Sunlight

Ask about HB631

Full bill text

Version HB631 · 2026-01-13 · Official source text

Full text

Changes in this version: added text deleted text

Be it enacted by the General Assembly of Virginia:

1. That § 32.1-325.5 of the Code of Virginia is amended and reenacted as follows:

§ 32.1-325.5. State pharmacy benefits manager.

A. As used in this section:

"Pharmacy benefits manager" means the same as that term is defined in § 38.2-3465.

"Spread pricing" means the model of prescription drug pricing in which the pharmacy benefits manager charges a managed care plan a contracted price for prescription drugs, and the contracted price for the prescription drugs differs from the amount the pharmacy benefits manager directly or indirectly pays the pharmacist or pharmacy for pharmacist services.

"State pharmacy benefits manager" means the pharmacy benefits manager contracted by the Department pursuant to this section to administer pharmacy benefits for all Medicaid recipients in the Commonwealth.

B. By July 1, 2026, the Department shall select and contract with a single third-party administrator to serve as the state pharmacy benefits manager to administer all pharmacy benefits for Medicaid recipients, including those enrolled in a managed care organization by such date with whom the Department contracts for the delivery of Medicaid services. Each managed care contract entered into or renewed by the Department for the delivery of Medicaid services by a managed care organization shall require the managed care organization to contract with and utilize the state pharmacy benefits manager for the purpose of administering all pharmacy benefits for Medicaid recipients enrolled with the managed care organization. Notwithstanding the provisions of § 38.2-3470, the state pharmacy benefits manager shall adhere to subdivision A 5 of § 38.2-3467 unless otherwise prohibited by federal law.

C. The Department's contract with the state pharmacy benefits manager shall:

1. Establish the state pharmacy benefits manager's fiduciary duty owed to the Department;

2. Require the use of pass-through pricing;

3. Require the state pharmacy benefits manager to use the common formulary, reimbursement methodologies, and dispensing fees negotiated by the Department, and require that ingredient-cost reimbursement is based on the national average drug acquisition cost, or if unavailable, the wholesale acquisition cost minus a discount set by the Department, plus a professional dispensing fee, determined by the Department;

4. Require real-time or near real-time transparency in drug costs, rebates collected and paid, dispensing fees paid, administrative fees, and all other charges, fees, costs, and holdbacks, claim denials appeals, and network participation; and

5. Prohibit the use of spread pricing;

6. Prohibit the state pharmacy benefits manager from steering Medicaid recipients to affiliated pharmacies through differential cost-sharing, restrictive network design, or the mandatory use of a mail order pharmacy provider;

7. Require the state pharmacy benefits manager to:

a. Meet network adequacy standards established by the Department based on geographic access, travel time, and availability of retail community pharmacies;

b. Allow any appropriately licensed pharmacy that agrees to the terms of a provider contract to participate in the pharmacy network under the same terms, conditions, and reimbursement methodologies, as any other pharmacy participating in the network;

c. Verify that all contracted pharmacies are actively accepting Medicaid recipients and to maintain accurate directory information;

d. Submit annual reports to the Department that contain the information described in subsection B of § 38.2-3468;

e. Disclose to the Department pricing and maximum acquisition cost methodologies, including a detailed explanation of how pharmacy reimbursement amounts are calculated, updated, and adjusted; and

f. Allow invoice-based or national average drug acquisition cost-based appeals and require an adjustment of rates network-wide when an appeal is upheld; and

8. Include enforcement mechanisms and monetary penalties for noncompliance.

D. The Department shall annually calculate the savings generated by the use of the state pharmacy benefits manager, which are the documented reduction in Medicaid pharmacy spending resulting from such use, including administrative consolidation, improved pricing accuracy through the use of the national average drug acquisition cost-based reimbursement, reduced overhead, greater transparency, and elimination of duplicative managed care organization pharmacy benefits manager contracts.

E. The Department shall annually increase its dispensing fee such that the Department's total annual amount spent on dispensing fees is increased by the amount calculated by the Department in accordance with subsection D. The Department shall annually publish and make available on its website its annual and total savings achieved, the annual and total amount applied to dispensing fees increases, and the updated dispensing fees.

F. The Department shall report by September 30 of each year to the General Assembly on the state pharmacy benefits manager's compliance with the provisions of this section, national average drug acquisition cost compliance, pharmacy reimbursement trends, network adequacy compliance, and dispensing fee sufficiency.

Legislative actions

2026-01-13 · history

Prefiled and ordered printed; Offered 01-14-2026 26103637D

2026-02-03 · history

Subcommittee recommends reporting with amendment(s) and referring to Appropriations

2026-02-13 · history

Subcommittee recommends laying on the table (6-Y 1-N)

2026-02-13 · history

Subcommittee recommends laying on the table

2026-01-13 · history

Referred to Committee on Labor and Commerce

2026-02-03 · history

Subcommittee recommends reporting with amendment(s) and referring to Appropriations (9-Y 0-N)

2026-02-05 · history

Reported from Labor and Commerce with amendment(s) and referred to Appropriations (21-Y 1-N)

2026-01-20 · history

Assigned HCL sub: Subcommittee #1

2026-02-05 · history

Assigned HAPP sub: Health & Human Resources

2026-02-05 · history

Reported from Labor and Commerce with amendment(s) and referred to Appropriations

2026-02-04 · history

Fiscal Impact Statement from Department of Planning and Budget (HB631)

2026-02-03 · history

House subcommittee offered

2026-02-18 · history

Left in Committee Appropriations

Raw source record
{
    "id": 84468,
    "url": "https:\/\/www.richmondsunlight.com\/bill\/2026\/hb631\/",
    "tags": {
        "152181": "pharmacy",
        "152182": "medicaid",
        "152183": "transparency",
        "152184": "regulation",
        "152185": "healthcare",
        "152186": "reporting",
        "154113": "contracts",
        "154114": "medication"
    },
    "text": [
        {
            "date": "2026-01-13",
            "number": "HB631",
            "pdf_url": "https:\/\/downloads.richmondsunlight.com\/bills\/2026\/hb631.pdf"
        }
    ],
    "type": "bill",
    "year": 2026,
    "video": null,
    "number": "hb631",
    "patron": "Callsen, Katrina",
    "status": "failed committee",
    "chamber": "house",
    "changes": null,
    "outcome": "failed",
    "related": [
        {
            "id": 85388,
            "name": "Education and Health",
            "year": 2026,
            "count": 3,
            "number": "sb410",
            "status": "incorporated",
            "catch_line": "Pharmacy benefits managers; various requirements; report.",
            "date_introduced": "January 13, 2026"
        },
        {
            "id": 85549,
            "name": "Education and Health",
            "year": 2026,
            "count": 3,
            "number": "sb545",
            "status": "failed committee",
            "catch_line": "Ivermectin; authorize over-the-counter sale.",
            "date_introduced": "January 14, 2026"
        },
        {
            "id": 84669,
            "name": "Rules",
            "year": 2026,
            "count": 3,
            "number": "hb831",
            "status": "failed committee",
            "catch_line": "Medication, drug, and vaccine ingredient labeling; Board of Pharmacy, et al., to study.",
            "date_introduced": "January 13, 2026"
        },
        {
            "id": 84436,
            "name": "Appropriations",
            "year": 2026,
            "count": 3,
            "number": "hb605",
            "status": "signed by governor",
            "catch_line": "Nursing facilities; Joint Commission on Health Care shall evaluate workforce, report.",
            "date_introduced": "January 13, 2026"
        },
        {
            "id": 86051,
            "name": "Education and Health",
            "year": 2026,
            "count": 3,
            "number": "sb808",
            "status": "failed committee",
            "catch_line": "Nursing facilities; related party rent disclosures, incentive payment reduction, penalty.",
            "date_introduced": "January 23, 2026"
        }
    ],
    "summary": "<b>State pharmacy benefits manager; contractual provisions; report.<\/b> Requires the Department of Medical Assistance Services' contract with the state pharmacy benefits manager to (i) require that that ingredient-cost reimbursement is based on the national average drug acquisition cost, or if unavailable, the wholesale acquisition cost minus a discount set by the Department, plus a professional dispensing fee, determined by the Department; (ii) require real-time or near real-time transparency in drug costs, rebates collected and paid, dispensing fees paid, administrative fees, and all other charges, fees, costs, and holdbacks, claim denials appeals, and network participation; (iii) prohibit the state pharmacy benefits manager from steering Medicaid recipients to affiliated pharmacies through differential cost-sharing, restrictive network design, or the mandatory use of a mail order pharmacy provider; (iv) require the state pharmacy benefits manager to (a) meet network adequacy standards established by the Department; (b) allow any willing pharmacy to participate in the pharmacy network; (c) verify that all contracted pharmacies are actively accepting Medicaid recipients; (d) submit annual reports containing certain information; (e) disclose to the Department pricing and maximum acquisition cost methodologies; and (f) allow invoice-based or national average drug acquisition cost-based appeals and require an adjustment of rates network-wide when an appeal is upheld; and (v) include enforcement mechanisms and monetary penalties for noncompliance. Additionally, the bill requires Department to annually calculate the savings generated by the use of the state pharmacy benefits manager and to annually increase its dispensing fee by the amount of such savings. The bill requires the Department to annually (1) publish and make available on its website its annual and total savings achieved, the annual and total amount applied to dispensing fees increases, and the updated dispensing fees and (2) report to the General Assembly on the state pharmacy benefits manager's compliance, national average drug acquisition cost compliance, pharmacy reimbursement trends, network adequacy compliance, and dispensing fee sufficiency.",
    "version": "HB631",
    "copatron": [
        {
            "shortname": "ntcole",
            "partisanship": null,
            "name_formatted": "Del. Nicole Cole (D-Spotsylvania)"
        },
        {
            "shortname": "erguzman",
            "partisanship": 16,
            "name_formatted": "Del. Elizabeth Guzman (D-Woodbridge)"
        },
        {
            "shortname": "howachsmann",
            "partisanship": 79,
            "name_formatted": "Del. Otto Wachsmann (R-Sussex)"
        }
    ],
    "committee": "Appropriations",
    "full_text": "<p class=enactstm>Be it enacted by the General Assembly of Virginia:<\/p>\n<p class=enactcls>1. That \u00a7&nbsp;<a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-325.5\/'>32.1-325.5<\/a> of the Code of Virginia is amended and reenacted as follows:<\/p>\n<p class=catchln>\u00a7&nbsp;<a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-325.5\/'>32.1-325.5<\/a>. State pharmacy benefits manager.<\/p>\n<p class=section>A. As used in this section:<\/p>\n<p class=section>\"Pharmacy benefits manager\" means the same as that term is defined in \u00a7&nbsp;<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3465\/'>38.2-3465<\/a>.<\/p>\n<p class=section>\"Spread pricing\" means the model of prescription drug pricing in which the pharmacy benefits manager charges a managed care plan a contracted price for prescription drugs, and the contracted price for the prescription drugs differs from the amount the pharmacy benefits manager directly or indirectly pays the pharmacist or pharmacy for pharmacist services.<\/p>\n<p class=section>\"State pharmacy benefits manager\" means the pharmacy benefits manager contracted by the Department pursuant to this section to administer pharmacy benefits for all Medicaid recipients in the Commonwealth.<\/p>\n<p class=section>B. By July 1, 2026, the Department shall select and contract with a single third-party administrator to serve as the state pharmacy benefits manager to administer all pharmacy benefits for Medicaid recipients, including those enrolled in a managed care organization by such date with whom the Department contracts for the delivery of Medicaid services. Each managed care contract entered into or renewed by the Department for the delivery of Medicaid services by a managed care organization shall require the managed care organization to contract with and utilize the state pharmacy benefits manager for the purpose of administering all pharmacy benefits for Medicaid recipients enrolled with the managed care organization. Notwithstanding the provisions of \u00a7&nbsp;<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3470\/'>38.2-3470<\/a>, the state pharmacy benefits manager shall adhere to subdivision A 5 of \u00a7&nbsp;<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3467\/'>38.2-3467<\/a> unless otherwise prohibited by federal law.<\/p>\n<p class=section>C. The Department's contract with the state pharmacy benefits manager shall:<\/p>\n<p class=section>1. Establish the state pharmacy benefits manager's fiduciary duty owed to the Department;<\/p>\n<p class=section>2. Require the use of pass-through pricing;<\/p>\n<p class=section>3. Require the state pharmacy benefits manager to use the common formulary, reimbursement methodologies, and dispensing fees negotiated by the Department<ins>,<\/ins><ins> <\/ins><ins>and<\/ins><ins> require that ingredient-cost reimbursement is based on the nati<\/ins><ins>onal average drug acquisition cost<\/ins><ins>, or if unavai<\/ins><ins>lable, <\/ins><ins>the wholesale acquisition cost minus a discount set by the Department<\/ins><ins>,<\/ins><ins> plus a professional dispensing fee, determined by the Department<\/ins>;<\/p>\n<p class=section>4. Require<ins> <\/ins><ins>real-time or near real-time<\/ins> transparency in drug costs, rebates collected and paid, dispensing fees paid, administrative fees,<s> and<\/s> all other charges, fees, costs, and holdbacks<ins>, claim denials appeals<\/ins><ins>, and network participation<\/ins>;<s> and<\/s><\/p>\n<p class=section>5. Prohibit the use of spread pricing<ins>;<\/ins><\/p>\n<p class=section><ins>6<\/ins><ins>.<\/ins><ins> <\/ins><ins>Prohibit the state pharmac<\/ins><ins>y benefits manager from <\/ins><ins>steering <\/ins><ins>Medicaid recipients to affiliated pharmacies through differential cost-sharing, restrictive network design, or the mandatory use of a <\/ins><ins>mail order pharmacy provider;<\/ins><\/p>\n<p class=section><ins>7. <\/ins><ins>Require the state pharmacy benefits manager<\/ins><ins> to:<\/ins><\/p>\n<p class=section><ins>a. Meet <\/ins><ins>network adequacy standards established by the <\/ins><ins>Department based on <\/ins><ins>geographic<\/ins><ins> access, travel time, and availability of <\/ins><ins>retail community<\/ins><ins> pharmacies;<\/ins><\/p>\n<p class=section><ins>b. Allow any appropriately licensed pharmacy that agrees to the terms of a provider contract t<\/ins><ins>o participate in the pharmacy network<\/ins><ins> under the same terms, conditions, and reimbursement<\/ins><ins> methodologies<\/ins><ins>,<\/ins><ins> as any other pharmacy participating <\/ins><ins>in <\/ins><ins>the network<\/ins><ins>;<\/ins><ins> <\/ins><\/p>\n<p class=section><ins>c.<\/ins><ins> Verify that all contracted pharmacies are actively accepting Medicaid recipients and to maintain <\/ins><ins>accurate directory information;<\/ins><\/p>\n<p class=section><ins>d. <\/ins><ins>Submit annual reports to the Department <\/ins><ins>t<\/ins><ins>hat contain the information <\/ins><ins>described in subsection B of \u00a7<\/ins><ins> <\/ins><ins><a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3468\/'>38.2-3468<\/a><\/ins><ins>; <\/ins><\/p>\n<p class=section><ins>e. Disclose <\/ins><ins>to the Department <\/ins><ins>pricing <\/ins><ins>and maximum acquisition cost <\/ins><ins>methodol<\/ins><ins>ogies, including<\/ins><ins> <\/ins><ins>a <\/ins><ins>detailed <\/ins><ins>explanation of how pharmacy reimbursement amounts are calculated, updated, and adjusted<\/ins><ins>;<\/ins><ins> and<\/ins><\/p>\n<p class=section><ins>f<\/ins><ins>. <\/ins><ins>Allow invoice<\/ins><ins>-based<\/ins><ins> or national average drug <\/ins><ins>acquisition<\/ins><ins> cost<\/ins><ins>-based<\/ins><ins> appeals and <\/ins><ins>require an adjustment of rates network-wide when an appeal is upheld<\/ins><ins>; and<\/ins><\/p>\n<p class=section><ins>8. Include enforcement mechanisms and monetary penalties for noncomp<\/ins><ins>l<\/ins><ins>iance<\/ins>.<\/p>\n<p class=section><ins>D. <\/ins><ins>The Department <\/ins><ins>shall <\/ins><ins>annual<\/ins><ins>ly<\/ins><ins> calculate the savings generated by the use of the state pharmacy benefits manager<\/ins><ins>, which are the documented reduction in Medicaid pharmacy spending resulting <\/ins><ins>from such use, including <\/ins><ins>administrative<\/ins><ins> consolidation, <\/ins><ins>improved<\/ins><ins> pricing accuracy through the use of the national average drug <\/ins><ins>acquisition<\/ins><ins> cost-based reimbursement, reduced overhead<\/ins><ins>, greater transparency, and elimination of duplicative managed care organization pharmacy benefits manager contracts.<\/ins><\/p>\n<p class=section><ins>E. <\/ins><ins>The Department shall<\/ins><ins> annually increase its dispensing fee suc<\/ins><ins>h that the <\/ins><ins>Department's total annual amount spent on dispensing fees is increased by the <\/ins><ins>amount calculated by the Department in accordance with subsection D. <\/ins><ins>The Department shall <\/ins><ins>annually <\/ins><ins>publish<\/ins><ins> and make available on its website<\/ins><ins> its <\/ins><ins>annual and total <\/ins><ins>savings <\/ins><ins>achieved<\/ins><ins>, the<\/ins><ins> annual and total<\/ins><ins> amount applied to dispensing fees<\/ins><ins> increases<\/ins><ins>, <\/ins><ins>and the updated dispensing fees<\/ins><ins>.<\/ins><ins> <\/ins><\/p>\n<p class=section><ins>F<\/ins><ins>. <\/ins><ins>The <\/ins><ins>Department shall <\/ins><ins>report <\/ins><ins>by September 30 of each year<\/ins><ins> to the General Assembly <\/ins><ins>on the state pharmacy benefits manager<\/ins><ins>'s compliance with the provisions of this section, national average drug <\/ins><ins>acquisition<\/ins><ins> <\/ins><ins>cost<\/ins><ins> compliance, pharmacy reimbursement trends, network <\/ins><ins>adequacy<\/ins><ins> compli<\/ins><ins>ance, and dispensing fee sufficiency.<\/ins><\/p>",
    "catch_line": "State pharmacy benefits manager; contractual provisions, report.",
    "duplicates": [
        {
            "year": 2027,
            "number": "sb668",
            "patron": "Rouse, Aaron",
            "status": "in committee",
            "chamber": "senate",
            "catch_line": "State pharmacy benefits manager; contractual provisions, report.",
            "date_introduced": "2026-01-14"
        },
        {
            "year": 2026,
            "number": "sb668",
            "patron": "Rouse, Aaron",
            "status": "failed committee",
            "chamber": "senate",
            "catch_line": "State pharmacy benefits manager; contractual provisions, report.",
            "date_introduced": "2026-01-14"
        }
    ],
    "session_id": 32,
    "word_count": 1198,
    "patron_party": "D",
    "patron_place": "Charlottesville",
    "summary_hash": "8817c530e934444360d38dbd2485a296",
    "patron_prefix": "Del.",
    "patron_suffix": "(D-Charlottesville)",
    "status_detail": "failed committee",
    "_rsun_versions": [
        {
            "id": "ba213876064003aaed36737675cf34db6ca8ae32a0c672107b27a9602c5232bd",
            "code": "HB631",
            "bill_id": 84468,
            "source_url": "https:\/\/downloads.richmondsunlight.com\/bills\/2026\/hb631.pdf",
            "source_date": "2026-01-13",
            "source_hash": "bdb390974638466ec55e68d3bcb264819fab832ba1774062051373d3c844dbd8",
            "source_html": "<p class=enactstm>Be it enacted by the General Assembly of Virginia:<\/p>\n<p class=enactcls>1. That \u00a7&nbsp;<a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-325.5\/'>32.1-325.5<\/a> of the Code of Virginia is amended and reenacted as follows:<\/p>\n<p class=catchln>\u00a7&nbsp;<a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-325.5\/'>32.1-325.5<\/a>. State pharmacy benefits manager.<\/p>\n<p class=section>A. As used in this section:<\/p>\n<p class=section>\"Pharmacy benefits manager\" means the same as that term is defined in \u00a7&nbsp;<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3465\/'>38.2-3465<\/a>.<\/p>\n<p class=section>\"Spread pricing\" means the model of prescription drug pricing in which the pharmacy benefits manager charges a managed care plan a contracted price for prescription drugs, and the contracted price for the prescription drugs differs from the amount the pharmacy benefits manager directly or indirectly pays the pharmacist or pharmacy for pharmacist services.<\/p>\n<p class=section>\"State pharmacy benefits manager\" means the pharmacy benefits manager contracted by the Department pursuant to this section to administer pharmacy benefits for all Medicaid recipients in the Commonwealth.<\/p>\n<p class=section>B. By July 1, 2026, the Department shall select and contract with a single third-party administrator to serve as the state pharmacy benefits manager to administer all pharmacy benefits for Medicaid recipients, including those enrolled in a managed care organization by such date with whom the Department contracts for the delivery of Medicaid services. Each managed care contract entered into or renewed by the Department for the delivery of Medicaid services by a managed care organization shall require the managed care organization to contract with and utilize the state pharmacy benefits manager for the purpose of administering all pharmacy benefits for Medicaid recipients enrolled with the managed care organization. Notwithstanding the provisions of \u00a7&nbsp;<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3470\/'>38.2-3470<\/a>, the state pharmacy benefits manager shall adhere to subdivision A 5 of \u00a7&nbsp;<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3467\/'>38.2-3467<\/a> unless otherwise prohibited by federal law.<\/p>\n<p class=section>C. The Department's contract with the state pharmacy benefits manager shall:<\/p>\n<p class=section>1. Establish the state pharmacy benefits manager's fiduciary duty owed to the Department;<\/p>\n<p class=section>2. Require the use of pass-through pricing;<\/p>\n<p class=section>3. Require the state pharmacy benefits manager to use the common formulary, reimbursement methodologies, and dispensing fees negotiated by the Department<ins>,<\/ins><ins> <\/ins><ins>and<\/ins><ins> require that ingredient-cost reimbursement is based on the nati<\/ins><ins>onal average drug acquisition cost<\/ins><ins>, or if unavai<\/ins><ins>lable, <\/ins><ins>the wholesale acquisition cost minus a discount set by the Department<\/ins><ins>,<\/ins><ins> plus a professional dispensing fee, determined by the Department<\/ins>;<\/p>\n<p class=section>4. Require<ins> <\/ins><ins>real-time or near real-time<\/ins> transparency in drug costs, rebates collected and paid, dispensing fees paid, administrative fees,<s> and<\/s> all other charges, fees, costs, and holdbacks<ins>, claim denials appeals<\/ins><ins>, and network participation<\/ins>;<s> and<\/s><\/p>\n<p class=section>5. Prohibit the use of spread pricing<ins>;<\/ins><\/p>\n<p class=section><ins>6<\/ins><ins>.<\/ins><ins> <\/ins><ins>Prohibit the state pharmac<\/ins><ins>y benefits manager from <\/ins><ins>steering <\/ins><ins>Medicaid recipients to affiliated pharmacies through differential cost-sharing, restrictive network design, or the mandatory use of a <\/ins><ins>mail order pharmacy provider;<\/ins><\/p>\n<p class=section><ins>7. <\/ins><ins>Require the state pharmacy benefits manager<\/ins><ins> to:<\/ins><\/p>\n<p class=section><ins>a. Meet <\/ins><ins>network adequacy standards established by the <\/ins><ins>Department based on <\/ins><ins>geographic<\/ins><ins> access, travel time, and availability of <\/ins><ins>retail community<\/ins><ins> pharmacies;<\/ins><\/p>\n<p class=section><ins>b. Allow any appropriately licensed pharmacy that agrees to the terms of a provider contract t<\/ins><ins>o participate in the pharmacy network<\/ins><ins> under the same terms, conditions, and reimbursement<\/ins><ins> methodologies<\/ins><ins>,<\/ins><ins> as any other pharmacy participating <\/ins><ins>in <\/ins><ins>the network<\/ins><ins>;<\/ins><ins> <\/ins><\/p>\n<p class=section><ins>c.<\/ins><ins> Verify that all contracted pharmacies are actively accepting Medicaid recipients and to maintain <\/ins><ins>accurate directory information;<\/ins><\/p>\n<p class=section><ins>d. <\/ins><ins>Submit annual reports to the Department <\/ins><ins>t<\/ins><ins>hat contain the information <\/ins><ins>described in subsection B of \u00a7<\/ins><ins> <\/ins><ins><a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3468\/'>38.2-3468<\/a><\/ins><ins>; <\/ins><\/p>\n<p class=section><ins>e. Disclose <\/ins><ins>to the Department <\/ins><ins>pricing <\/ins><ins>and maximum acquisition cost <\/ins><ins>methodol<\/ins><ins>ogies, including<\/ins><ins> <\/ins><ins>a <\/ins><ins>detailed <\/ins><ins>explanation of how pharmacy reimbursement amounts are calculated, updated, and adjusted<\/ins><ins>;<\/ins><ins> and<\/ins><\/p>\n<p class=section><ins>f<\/ins><ins>. <\/ins><ins>Allow invoice<\/ins><ins>-based<\/ins><ins> or national average drug <\/ins><ins>acquisition<\/ins><ins> cost<\/ins><ins>-based<\/ins><ins> appeals and <\/ins><ins>require an adjustment of rates network-wide when an appeal is upheld<\/ins><ins>; and<\/ins><\/p>\n<p class=section><ins>8. Include enforcement mechanisms and monetary penalties for noncomp<\/ins><ins>l<\/ins><ins>iance<\/ins>.<\/p>\n<p class=section><ins>D. <\/ins><ins>The Department <\/ins><ins>shall <\/ins><ins>annual<\/ins><ins>ly<\/ins><ins> calculate the savings generated by the use of the state pharmacy benefits manager<\/ins><ins>, which are the documented reduction in Medicaid pharmacy spending resulting <\/ins><ins>from such use, including <\/ins><ins>administrative<\/ins><ins> consolidation, <\/ins><ins>improved<\/ins><ins> pricing accuracy through the use of the national average drug <\/ins><ins>acquisition<\/ins><ins> cost-based reimbursement, reduced overhead<\/ins><ins>, greater transparency, and elimination of duplicative managed care organization pharmacy benefits manager contracts.<\/ins><\/p>\n<p class=section><ins>E. <\/ins><ins>The Department shall<\/ins><ins> annually increase its dispensing fee suc<\/ins><ins>h that the <\/ins><ins>Department's total annual amount spent on dispensing fees is increased by the <\/ins><ins>amount calculated by the Department in accordance with subsection D. <\/ins><ins>The Department shall <\/ins><ins>annually <\/ins><ins>publish<\/ins><ins> and make available on its website<\/ins><ins> its <\/ins><ins>annual and total <\/ins><ins>savings <\/ins><ins>achieved<\/ins><ins>, the<\/ins><ins> annual and total<\/ins><ins> amount applied to dispensing fees<\/ins><ins> increases<\/ins><ins>, <\/ins><ins>and the updated dispensing fees<\/ins><ins>.<\/ins><ins> <\/ins><\/p>\n<p class=section><ins>F<\/ins><ins>. <\/ins><ins>The <\/ins><ins>Department shall <\/ins><ins>report <\/ins><ins>by September 30 of each year<\/ins><ins> to the General Assembly <\/ins><ins>on the state pharmacy benefits manager<\/ins><ins>'s compliance with the provisions of this section, national average drug <\/ins><ins>acquisition<\/ins><ins> <\/ins><ins>cost<\/ins><ins> compliance, pharmacy reimbursement trends, network <\/ins><ins>adequacy<\/ins><ins> compli<\/ins><ins>ance, and dispensing fee sufficiency.<\/ins><\/p>",
            "source_metadata": {
                "bodyAssociation": "archive-reported-current-version",
                "archiveReference": {
                    "date": "2026-01-13",
                    "number": "HB631",
                    "pdf_url": "https:\/\/downloads.richmondsunlight.com\/bills\/2026\/hb631.pdf"
                }
            }
        }
    ],
    "copatron_count": 3,
    "patron_address": [
        "P.O. Box 442",
        "Charlottesville",
        "VA 22902"
    ],
    "patron_chamber": "house",
    "patron_started": 2024,
    "session_lis_id": 261,
    "status_history": [
        {
            "date": "02\/18\/2026",
            "status": "Left in Committee Appropriations",
            "date_raw": "2026-02-18",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "failed committee"
        },
        {
            "date": "02\/13\/2026",
            "status": "Subcommittee recommends laying on the table (6-Y 1-N)",
            "date_raw": "2026-02-13",
            "vote_count": null,
            "lis_vote_id": "297409",
            "translation": "failed subcommittee"
        },
        {
            "date": "02\/13\/2026",
            "status": "Subcommittee recommends laying on the table",
            "date_raw": "2026-02-13",
            "vote_count": null,
            "lis_vote_id": "297409",
            "translation": "failed subcommittee"
        },
        {
            "date": "02\/05\/2026",
            "status": "Reported from Labor and Commerce with amendment(s) and referred to Appropriations (21-Y 1-N)",
            "date_raw": "2026-02-05",
            "vote_count": null,
            "lis_vote_id": "294888",
            "translation": "passed committee"
        },
        {
            "date": "02\/05\/2026",
            "status": "Assigned HAPP sub: Health & Human Resources",
            "date_raw": "2026-02-05",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in subcommittee"
        },
        {
            "date": "02\/05\/2026",
            "status": "Reported from Labor and Commerce with amendment(s) and referred to Appropriations",
            "date_raw": "2026-02-05",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "passed committee"
        },
        {
            "date": "02\/04\/2026",
            "status": "Fiscal Impact Statement from Department of Planning and Budget (HB631)",
            "date_raw": "2026-02-04",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/03\/2026",
            "status": "Subcommittee recommends reporting with amendment(s) and referring to Appropriations (9-Y 0-N)",
            "date_raw": "2026-02-03",
            "vote_count": null,
            "lis_vote_id": "294264",
            "translation": "passed subcommittee"
        },
        {
            "date": "02\/03\/2026",
            "status": "Subcommittee recommends reporting with amendment(s) and referring to Appropriations",
            "date_raw": "2026-02-03",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "passed subcommittee"
        },
        {
            "date": "02\/03\/2026",
            "status": "House subcommittee offered",
            "date_raw": "2026-02-03",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "01\/20\/2026",
            "status": "Assigned HCL sub: Subcommittee #1",
            "date_raw": "2026-01-20",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in subcommittee"
        },
        {
            "date": "01\/13\/2026",
            "status": "Referred to Committee on Labor and Commerce",
            "date_raw": "2026-01-13",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in committee"
        },
        {
            "date": "01\/13\/2026",
            "status": "Prefiled and ordered printed; Offered 01-14-2026 26103637D",
            "date_raw": "2026-01-13",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "introduced"
        }
    ],
    "chief_patron_id": 497,
    "date_introduced": "2026-01-13",
    "patron_district": 54,
    "patron_shortname": "kcallsen",
    "committee_chamber": "house",
    "status_detail_date": "02\/18\/2026",
    "committee_shortname": "appropriations",
    "patron_name_formatted": "Del. Katrina Callsen (D-Charlottesville)"
}